Driving Fast, Accurate Diagnosis for All Skin Cancers
Dermalyser is a diagnostic decision support system (DDSS) empowered with advanced artificial intelligence (AI). The primary function is to classify skin cancer such as malignant melanoma using image analysis combined with deep learning (AI). The artificial intelligence is developed and trained based on quality-controlled dermatoscopic images of patients’ skin lesions together with associated patient data. Medical professionals, for example general practitioners, use the solution/application on a mobile phone together with a dermatoscope mounted in front of the mobile phone camera. The general practitioner takes a picture of the patient’s skin lesion and receives a melanoma risk label within a few seconds with higher diagnostic precision and speed than traditional and alternative methods.
Watch our short demonstration video to see how Dermalyser works.
How Dermalyser Works
Dermalyser is extremely practical and easy to use, and can be integrated into routine clinical practice in four simple steps.
Performance (AUC) of Dermalyser
In a test with more than 6000 unseen images, our AI achieved an AUC score of 0.94 which significantly outperforms Expert Dermatologists and General Practitioners.
Advantages of Using Dermalyser
Dermalyser offers multiple benefits over traditional diagnostic pathways for skin cancer and other available solutions.
Fewer Melanomas Missed And Increased Performance
We have a carefully curated database comprising over 100,000 images of fully labelled skin lesions that have been used to train our proprietary AI, enabling industry leading sensitivity and better performance.
Reduced Number of Unnecessary Skin Excisions
Supports reduction of unnecessary skin excisions thereby improving healthcare economics across multiple levels.
Easy And Convenient
AI empowered image analysis software enables easy analysis of a patient’s skin lesion on any mobile phone.